For the first time, our results indicated that Ganoderma lucidum polysaccharide plant extract increases apoptosis in both prostate cancer cell lines and modulates the EMT pathway and KLK2 biomarker in favor of better response to treatment. The gene discussed is KLK2; the disease is prostate carcinoma.